Clinical Trials Directory

Trials / Completed

CompletedNCT03379740

Study to Investigate the Nicotine Pharmacokinetic Profiles and Pharmacodynamic Effects of P4M3 Variants

A Single-center, Open-label, Concentration-ranging Study to Investigate the Nicotine Pharmacokinetic Profiles and Pharmacodynamic Effects of the P4M3 Variants

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
15 (actual)
Sponsor
Philip Morris Products S.A. · Industry
Sex
All
Age
21 Years – 65 Years
Healthy volunteers
Accepted

Summary

This is a single-center, open-label, concentration-ranging study to evaluate the nicotine PK profile and PD effects in healthy adult experienced users of closed tank/cartridge e-cigarettes using four different variants of P4M3 (nicotine concentration of 1.7%, 1.7% with 1.1% lactic acid \[LA\], 3% with 1.1% LA, and 4% with 2% LA) or their own e-cigarettes.

Detailed description

The goal of the study is to evaluate the nicotine concentration profiles and derived PK parameters, subjective effects, behavioral parameters, including puffing topography parameters of P4M3 with four different variants of P4M3, in experienced e-cigarette users after a single-use experience with fixed puffing regime and after ad libitum use of P4M3. Four variants of P4M3 will be evaluated together with subjects' own e-cigarettes to evaluate the relationship between the e-liquid composition (nicotine concentrations and presence of lactic acid) and the amount of nicotine absorbed, the speed of absorption, and the puffing topography.

Conditions

Interventions

TypeNameDescription
OTHERE-cigaretteSubject's own e-cigarette
OTHERP4M3-1.7%P4M3 e-liquid concentration of 1.7% nicotine without lactic acid
OTHERP4M3-1.7%LAP4M3 e-liquid concentration of 1.7% nicotine with lactic acid
OTHERP4M3-3%LAP4M3 e-liquid concentration of 3% nicotine with lactic acid
OTHERP4M3-4%LAP4M3 e-liquid concentration of 4% nicotine with lactic acid

Timeline

Start date
2017-07-11
Primary completion
2017-08-14
Completion
2017-12-01
First posted
2017-12-20
Last updated
2019-11-22
Results posted
2019-11-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03379740. Inclusion in this directory is not an endorsement.